Zhejiang Starry Pharmaceutical Co.,Ltd.

¥8.18As of Sun 8 Nov 2026, 12:00 UTC
SSE:603520Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.55%)
Div yield 3.67%
ROE 1.04%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.61
PE TTM 166.6
TSR TTM (24.32%)
Mkt cap ¥3.586B
ROIC 1.60%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.92
9.03%
(94.75%)
Hold 1|7|7|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.13
0.14
12.00%
13.83%
19.95%
33.40%
Revenue¥M
164.9
161.8
168.2
164.1
7.22%
2.28%
2.11%
(2.04%)
Peers (US$537.6M)
Cap (US$)
PE
537.1M
181.3x
534.0M
18.71x
Capital
TTM
5Y
10Y
Leveragex
12.78
(0.030)
(0.040)
EBIT/Intx
2.256
0.081
0.079
Own earn%
65.54
(126.76)
(63.08)
Sh yield%
33.02
54.78
53.83
Owners
Insiders/Inst%
11.61
72.28
Short interest%
4.13
SBC / revenue%
2.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
0–2
$1 testx
—
Incr. ROIC%
10